SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

D'ABUNDO, Lucilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.903
EU - Europa 1.640
AS - Asia 1.369
SA - Sud America 185
AF - Africa 34
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.813
SG - Singapore 492
DE - Germania 475
CN - Cina 323
PL - Polonia 300
IT - Italia 279
FI - Finlandia 265
VN - Vietnam 169
BR - Brasile 133
HK - Hong Kong 94
BD - Bangladesh 84
GB - Regno Unito 82
UA - Ucraina 63
CA - Canada 51
TR - Turchia 44
ID - Indonesia 39
FR - Francia 38
SE - Svezia 37
JP - Giappone 32
IN - India 27
MX - Messico 26
AR - Argentina 25
RU - Federazione Russa 23
ES - Italia 16
NL - Olanda 14
CZ - Repubblica Ceca 11
IQ - Iraq 11
ZA - Sudafrica 11
LT - Lituania 9
AT - Austria 7
CO - Colombia 7
UZ - Uzbekistan 6
EG - Egitto 5
MY - Malesia 5
PK - Pakistan 5
SA - Arabia Saudita 5
VE - Venezuela 5
BO - Bolivia 4
CL - Cile 4
KR - Corea 4
MA - Marocco 4
AU - Australia 3
HR - Croazia 3
JM - Giamaica 3
OM - Oman 3
PH - Filippine 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AZ - Azerbaigian 2
BE - Belgio 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EC - Ecuador 2
ET - Etiopia 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
LV - Lettonia 2
PS - Palestinian Territory 2
RO - Romania 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GY - Guiana 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
TH - Thailandia 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.135
Salva come PNG Salva come JPEG
Città #
Munich 409
Ashburn 408
Singapore 302
Warsaw 297
Fairfield 247
San Jose 247
Helsinki 197
Woodbridge 174
Houston 135
Beijing 125
Seattle 119
Chandler 110
Santa Clara 100
Wilmington 99
Cambridge 95
Hong Kong 89
Ann Arbor 77
Ferrara 75
Jacksonville 71
New York 71
Los Angeles 62
Ho Chi Minh City 51
Dallas 47
Jakarta 34
Milan 34
Tokyo 32
Hanoi 31
Council Bluffs 28
Nanjing 26
Shanghai 26
London 25
Turku 24
Orem 22
Lauterbourg 21
Atlanta 20
Izmir 20
Jyväskylä 20
Montreal 20
Chicago 19
Princeton 19
São Paulo 19
Rome 15
Turin 15
San Diego 14
Denver 13
Mexico City 13
Phoenix 13
Toronto 13
Boardman 12
Bologna 11
Nanchang 11
Dong Ket 10
Nuremberg 10
Buffalo 9
Manchester 9
Mountain View 9
San Francisco 9
Stockholm 9
Chennai 8
Johannesburg 8
Shenyang 8
Boston 7
Da Nang 7
Falls Church 7
Redwood City 7
Addison 6
Bremen 6
Brno 6
Haiphong 6
Hefei 6
Poplar 6
Tashkent 6
Baghdad 5
Dearborn 5
Guangzhou 5
Hebei 5
Naples 5
Pavia 5
Salt Lake City 5
Somerville 5
Tianjin 5
Vancouver 5
Vienna 5
Zhengzhou 5
Ankara 4
Belo Horizonte 4
Brooklyn 4
Cagliari 4
Changsha 4
Guarulhos 4
Honolulu 4
Kunming 4
Lancaster 4
Moscow 4
New Delhi 4
Ningbo 4
Ninh Bình 4
Quảng Ngãi 4
Riyadh 4
The Dalles 4
Totale 4.460
Salva come PNG Salva come JPEG
Nome #
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 403
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 372
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 310
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 302
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 301
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 291
Studi pre-clinici per lo sviluppo di approcci terapeutici basati sui microRNA in un modello di Leucemia Linfatica Cronica 282
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 269
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 266
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 255
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 244
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 240
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 240
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 237
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 230
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 203
Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy 193
Mutated beta-catenin evades a microRNA-dependent regulatory loop 189
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 184
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 173
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 172
FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells 165
Erratum: miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 139
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 131
Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells 104
P3.12.20 VAF of EGFR Mutations in Relation to Early Tumor Shrinkage or Deepness of Response During Osimertinib in NSCLC Patients 102
null 89
null 63
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer 60
The Effects of Variant Allele Frequency for EGFR Mutation on Early Tumor Shrinkage and Deepness of Response to Osimertinib in Patients with Metastatic Non-Small Cell Lung Cancer: An Exploratory Analysis 19
Totale 6.228
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.285
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022222 11 20 23 3 10 13 10 15 6 18 25 68
2022/2023246 19 19 12 29 44 33 17 17 30 3 13 10
2023/2024238 13 21 9 5 17 48 12 48 1 9 4 51
2024/20251.393 20 17 59 37 90 186 217 144 279 91 111 142
2025/20262.351 235 52 136 276 341 159 347 124 217 230 156 78
2026/202734 34 0 0 0 0 0 0 0 0 0 0 0
Totale 6.228